Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation.
Context. - The Agency for Health Care Policy and Research (AHCPR) published the Smoking Cessation : Clinical Practice Guideline in 1996.
Based on the results of meta-analyses and expert opinion, the guideline identifies efficacious interventions for primary care clinicians and smoking cessation specialty providers.
- To determine the cost-effectiveness of clinical recommendations in AHCPR's guideline.
- The guideline's 15 recommended smoking cessation interventions were analyzed to determine their relative cost-effectiveness.
Then, using decision probabilities, the interventions were combined into a global model of the guideline's overall cost-effectiveness.
- The analysis assumes that primary care clinicians screen all presenting adults for smoking status and advise and motivate all smokers to quit during the course of a routine office visit or hospitalization.
Smoking cessation interventions are provided to 75% of US smokers 18 years and older who are assumed to be willing to make a quit attempt during a year's time.
- Three counseling interventions for primary care clinicians and 2 counseling interventions for smoking cessation specialists were modeled with and without transdermal nicotine and nicotine gum.
Main Outcome Measure
- Cost (1995 dollars) per life-year or quality-adjusted life-year (QALY) saved, at a discount of 3%. Results. - The guideline would cost $6.3 billion to implement in its first year. (...)
Mots-clés Pascal : Tabagisme, Recommandation, Sevrage, Organisation nationale, Santé, Evaluation, Analyse avantage coût, Homme, Toxicomanie, Economie santé
Mots-clés Pascal anglais : Tobacco smoking, Recommendation, Weaning, National organisation, Health, Evaluation, Cost benefit analysis, Human, Drug addiction, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0041618
Code Inist : 002B30A01C. Création : 17/04/1998.